Exclusive: AstraZeneca pauses $270 million investment in Britain

Group 1 - AstraZeneca has paused a planned investment of 200 million pounds ($271.26 million) in its Cambridge research site [1] - This decision marks the latest retreat by a drugmaker from the UK [1]